propranolol has been researched along with Vestibular Diseases in 5 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to determine the efficacy of propranolol treatment in patients with vestibular migraine by the Visual Analog Scale, Dizziness Handicap Inventory (DHI), Vertigo Symptom Scale, and Vestibular Disorders Activities of Daily Living Scale (VADL) and its effect on the quality of life." | 3.96 | The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life. ( Çelik, O; Eskiizmir, G; İncesulu, A; Şahin Süyür, N; Tanyeri Toker, G, 2020) |
| "Vestibular migraine (VM) consists of recurrent episodes of vestibular symptoms that are accompanied by migraine in at least 50% of the episodes." | 1.56 | Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug. ( Álvarez-Morujo de Sande, MG; Bécares-Martínez, C; Domènech-Vadillo, E; Domínguez-Durán, E; González-Aguado, R; Guerra-Jiménez, G; Montilla-Ibáñez, MA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domínguez-Durán, E | 1 |
| Montilla-Ibáñez, MA | 1 |
| Álvarez-Morujo de Sande, MG | 1 |
| Domènech-Vadillo, E | 1 |
| Bécares-Martínez, C | 1 |
| González-Aguado, R | 1 |
| Guerra-Jiménez, G | 1 |
| Çelik, O | 1 |
| Tanyeri Toker, G | 1 |
| Eskiizmir, G | 1 |
| İncesulu, A | 1 |
| Şahin Süyür, N | 1 |
| Vignaux, G | 1 |
| Ndong, JD | 1 |
| Perrien, DS | 1 |
| Elefteriou, F | 1 |
| Salviz, M | 1 |
| Yuce, T | 1 |
| Acar, H | 1 |
| Karatas, A | 1 |
| Acikalin, RM | 1 |
| Kawao, N | 1 |
| Morita, H | 1 |
| Obata, K | 1 |
| Tamura, Y | 1 |
| Okumoto, K | 1 |
| Kaji, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Trial of Galcanezumab for Vestibular Migraine[NCT04417361] | Phase 2 | 50 participants (Anticipated) | Interventional | 2020-09-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for propranolol and Vestibular Diseases
| Article | Year |
|---|---|
Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Middl | 2016 |
4 other studies available for propranolol and Vestibular Diseases
| Article | Year |
|---|---|
Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug.
Topics: Acetazolamide; Amitriptyline; Analgesics; Central Nervous System Agents; Flunarizine; Humans; Migrai | 2020 |
The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life.
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Case-Control Studies; Dizzines | 2020 |
Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System.
Topics: Animals; Bone Remodeling; Female; Mice; Mice, Knockout; Osteoblasts; Osteoporosis; Propranolol; Symp | 2015 |
The vestibular system is critical for the changes in muscle and bone induced by hypergravity in mice.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Body Weight; Bone Density; Hypergra | 2016 |